Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025, along with a revision number change from v2.16.2 to v2.16.4.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has been updated to announce a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation.SummaryDifference7%
- Check56 days agoChange DetectedThe date for an event has been updated from November 14, 2024, to May 6, 2025.SummaryDifference1.0%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check78 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.